Axogen, Inc. (0HKD)
LSE
Closed
Oct 7, 2026
Day's Range
36.0052 wk Range
15.38Overview - 0HKD - Axogen, Inc.
Key Statistics
Valuation
Enterprise Value
2.25B
Price / Book
‪9.12‬
EV / EBITDA
‪-377.40‬
Profitability
Profit Margin
‪-13.35%‬
Operating Margin
‪-3.09%‬
Return on Assets
‪-3.14%‬
Return on Equity
‪-18.20%‬
Ownership
Shares Outstanding
38.67M
Float
52.71M
Held by Insiders
‪1.98%‬
Held by Institutions
‪90.93%‬
Price stats
Beta
‪1.16‬
50-Day Avg
‪9.10‬
200-Day Avg
‪7.35‬
Market Cap - 0HKD - Axogen, Inc.
Peers - 0HKD - Axogen, Inc.
Peer Comparison
Compared with companies in Medical Devices listed on LSE.
- 0HKDLSEAxogen, Inc.1.68BMarket Cap+61.21%52-week change—P/E (Trailing)‪-13.35%‬Profit Margin
- SVSLSESavills PLC177.85BMarket Cap+15.05%52-week change22.83P/E (Trailing)‪2.49%‬Profit Margin
- 0Q15LSEAbbott Laboratories168.67BMarket Cap-38.26%52-week change45.46P/E (Trailing)‪12.91%‬Profit Margin
- 0Y6XLSEMedtronic plc118.72BMarket Cap-6.44%52-week change0.24P/E (Trailing)‪13.93%‬Profit Margin
- 0R2SLSEStryker Corp.102.51BMarket Cap-34.20%52-week change0.52P/E (Trailing)‪14.43%‬Profit Margin
- PRNLSEPrinces Group plc81.73BMarket Cap-42.22%52-week change23.86P/E (Trailing)‪1.90%‬Profit Margin
- 0RGTLSEDemant A/S76.63BMarket Cap+25.99%52-week change29.38P/E (Trailing)‪7.55%‬Profit Margin
Profile Summary - 0HKD - Axogen, Inc.
About
Axogen, Inc. is a medical technology company focused on peripheral nerve regeneration and repair. Axogen develops and commercializes surgical solutions used by surgeons and healthcare providers to address nerve injuries caused by trauma, procedures, or disease. Its current product portfolio includes nerve allografts,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
